| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |